Cannabis Suisse Corp. (CSUI) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CSUI representa a Cannabis Suisse Corp., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). Calificado con 39/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026Cannabis Suisse Corp. (CSUI) Resumen de Asistencia Médica y Tuberías
Cannabis Suisse Corp. is a healthcare company focused on over-the-counter products, recreational tobacco, and medical CBD oils, distributed through its Swiss4Life brand and a retail network. With a high profit margin but negative gross margin, the company operates in a competitive and evolving market landscape.
Tesis de Inversión
Cannabis Suisse Corp. presents a complex investment profile. While the company boasts a high profit margin of 1469.1%, its negative gross margin of -54.7% raises concerns about operational efficiency and cost management. The company's focus on over-the-counter products, recreational tobacco, and medical CBD oils positions it in a market with both growth potential and regulatory uncertainty. Key value drivers include the expansion of its Swiss4Life brand and the establishment of strategic retail partnerships. Upcoming regulatory changes in the cannabis industry could significantly impact the company's operations and profitability. Investors should closely monitor the company's ability to improve its gross margin and navigate the evolving regulatory landscape.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Profit Margin of 1469.1% indicates high profitability, but needs further investigation into the drivers and sustainability.
- Negative Gross Margin of -54.7% signals potential issues with cost of goods sold and pricing strategies.
- Market Cap of $0.00B indicates the company is a micro-cap stock with high volatility and risk.
- P/E Ratio of 7.70 suggests the stock may be undervalued compared to its earnings, but should be considered alongside other financial metrics.
- Beta of -4.65 indicates the stock is negatively correlated with the market, which may offer diversification benefits but also reflects unique company-specific risks.
Competidores y Pares
Fortalezas
- Established Swiss4Life online retail brand.
- Diversified product line including cannabis-related and health-related products.
- Early mover advantage in the emerging cannabis market.
- High reported profit margin (though offset by negative gross margin).
Debilidades
- Negative gross margin indicates potential issues with cost management.
- Limited market capitalization and potential liquidity concerns.
- Reliance on a relatively new and evolving regulatory landscape.
- Limited brand recognition compared to larger competitors.
Catalizadores
- Ongoing: Expansion of the Swiss4Life brand through digital marketing and e-commerce initiatives.
- Ongoing: Strategic partnerships with major retailers to expand distribution network.
- Ongoing: Product diversification to include new and innovative health and wellness products.
- Upcoming: Potential changes in cannabis regulations that could create new market opportunities.
- Ongoing: Geographic expansion into new and emerging cannabis markets.
Riesgos
- Ongoing: Intense competition from established pharmaceutical companies and emerging cannabis businesses.
- Ongoing: Evolving regulatory landscape and potential changes in cannabis laws.
- Potential: Fluctuations in commodity prices and supply chain disruptions.
- Potential: Negative public perception and potential health concerns related to cannabis and tobacco products.
- Ongoing: Negative gross margin indicating potential issues with cost management.
Oportunidades de crecimiento
- Expansion of Swiss4Life Brand: Cannabis Suisse Corp. can leverage its Swiss4Life brand to expand its online presence and direct-to-consumer sales. The global e-commerce market is projected to reach trillions of dollars in the coming years, offering a significant opportunity for growth. By investing in digital marketing and enhancing its online platform, the company can attract new customers and increase brand loyalty. Timeline: Ongoing.
- Strategic Retail Partnerships: Establishing partnerships with major retailers can significantly expand Cannabis Suisse Corp.'s distribution network and market reach. The retail industry is evolving, with consumers increasingly seeking health and wellness products in convenient locations. By securing shelf space in established retail chains, the company can increase product visibility and drive sales. Timeline: Ongoing.
- Product Diversification: Expanding the product line to include new and innovative health and wellness products can attract a broader customer base and increase revenue streams. The health and wellness market is constantly evolving, with new trends and consumer demands emerging regularly. By investing in research and development, Cannabis Suisse Corp. can create unique and differentiated products that meet the needs of its target market. Timeline: Ongoing.
- Geographic Expansion: Entering new geographic markets can significantly increase Cannabis Suisse Corp.'s growth potential. The global cannabis market is expanding rapidly, with new countries and regions legalizing cannabis for medical and recreational use. By carefully selecting target markets and adapting its products to local regulations and consumer preferences, the company can capitalize on this growth opportunity. Timeline: Upcoming.
- Regulatory Changes: Upcoming changes in cannabis regulations could create new opportunities for Cannabis Suisse Corp. As more jurisdictions legalize cannabis, the company can expand its operations and enter new markets. By staying informed about regulatory developments and adapting its business model accordingly, Cannabis Suisse Corp. can capitalize on these opportunities and gain a competitive advantage. Timeline: Ongoing.
Oportunidades
- Expansion of the Swiss4Life brand through digital marketing and e-commerce initiatives.
- Strategic partnerships with major retailers to expand distribution network.
- Product diversification to include new and innovative health and wellness products.
- Geographic expansion into new and emerging cannabis markets.
Amenazas
- Increasing competition from established pharmaceutical companies and emerging cannabis businesses.
- Evolving regulatory landscape and potential changes in cannabis laws.
- Fluctuations in commodity prices and supply chain disruptions.
- Negative public perception and potential health concerns related to cannabis and tobacco products.
Ventajas competitivas
- Established Swiss4Life online retail brand.
- Network of retail distribution partners.
- Diversified product line including cannabis-related and health-related products.
- Early mover advantage in the emerging cannabis market.
Acerca de CSUI
Cannabis Suisse Corp., formerly Geant Corp., was established in 2016 and rebranded in February 2019 to reflect its focus on cannabis-related products. Headquartered in Bell Gardens, California, the company cultivates, produces, and distributes a range of products including over-the-counter health supplements, recreational tobacco products, and medical CBD oils. Its primary retail channel is Swiss4Life, an online brand, supplemented by a network of retailers. The product line extends beyond cannabis-related items to include health-related supplements, face masks, disinfectants, and traditional cigarettes. This diversified approach aims to capture a broader market segment within the health and wellness sector. The company's strategy involves leveraging both direct-to-consumer online sales and established retail partnerships to enhance market penetration and brand visibility. Cannabis Suisse Corp. operates within the evolving regulatory landscape of the cannabis industry, adapting its business model to comply with local and international laws.
Qué hacen
- Cultivates and produces over-the-counter products.
- Manufactures and distributes recreational tobacco products.
- Produces and sells medical CBD oils.
- Sells products through the Swiss4Life online retail brand.
- Distributes products through a network of retailers.
- Offers health-related supplements.
- Provides face masks and disinfectants.
- Retails cigarettes.
Modelo de Negocio
- Cultivation and production of cannabis-related products.
- Direct-to-consumer sales through the Swiss4Life online platform.
- Distribution through a network of retail partners.
- Sales of health-related supplements and other wellness products.
Contexto de la Industria
Cannabis Suisse Corp. operates within the specialty and generic drug manufacturing industry, a segment of the broader healthcare sector. The industry is characterized by intense competition, evolving regulatory landscapes, and increasing consumer demand for health and wellness products. Market trends include the growing acceptance of CBD products and the legalization of cannabis in various jurisdictions. Cannabis Suisse Corp. competes with established pharmaceutical companies and emerging cannabis businesses, navigating a complex environment of regulatory compliance and market differentiation. The company's success depends on its ability to innovate, adapt to changing regulations, and effectively market its products to a diverse consumer base.
Clientes Clave
- Consumers seeking over-the-counter health and wellness products.
- Individuals interested in recreational tobacco products.
- Patients seeking medical CBD oils for therapeutic purposes.
- Online shoppers through the Swiss4Life platform.
- Retail customers through the company's network of retail partners.
Finanzas
Gráfico e información
Precio de la acción de Cannabis Suisse Corp. (CSUI): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para CSUI.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CSUI.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CSUI.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CSUI en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Scott W. Mcalister
CEO
Information on Scott W. Mcalister's background is not available in the provided context. Further research would be needed to determine his career history, education, and previous roles.
Historial: Information on Scott W. Mcalister's track record is not available in the provided context. Further research would be needed to determine his key achievements, strategic decisions, and company milestones under his leadership.
Información del mercado OTC de CSUI
The OTC Other tier represents the lowest tier of the OTC market, indicating that Cannabis Suisse Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, and trading activity can be sporadic. Investing in OTC Other stocks carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in companies on this tier.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Potential for fraud and manipulation.
- Low trading volume and liquidity.
- Wider bid-ask spreads and price volatility.
- Lack of regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with the OTC market and the company's specific industry.
- Consult with a financial advisor before making any investment decisions.
- Company's operational history since 2016.
- Existence of a retail brand (Swiss4Life).
- Engagement in cultivation, production, and distribution activities.
- Physical headquarters in Bell Gardens, California.
Preguntas Comunes Sobre CSUI
¿Cuáles son los factores clave para evaluar CSUI?
Cannabis Suisse Corp. (CSUI) actualmente tiene una puntuación IA de 39/100, indicando puntuación baja. Fortaleza clave: Established Swiss4Life online retail brand.. Riesgo principal a monitorear: Ongoing: Intense competition from established pharmaceutical companies and emerging cannabis businesses.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CSUI?
CSUI actualmente puntúa 39/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CSUI?
Los precios de CSUI se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CSUI?
La cobertura de analistas para CSUI incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CSUI?
Las categorías de riesgo para CSUI incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition from established pharmaceutical companies and emerging cannabis businesses.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CSUI?
La relación P/E para CSUI compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CSUI sobrevalorada o infravalorada?
Determinar si Cannabis Suisse Corp. (CSUI) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CSUI?
Cannabis Suisse Corp. (CSUI) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available on CEO's background and track record.
- OTC market stocks are inherently riskier than exchange-listed stocks.